|
|
|
Insider
Information: |
Sachdev Amit |
Relationship: |
|
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
71,325 |
|
Indirect Shares
|
7,447 |
|
|
Direct
Value |
$24,511,741 |
|
|
Indirect Value
|
$3,299,393 |
|
|
Total
Shares |
78,772 |
|
|
Total
Value |
$27,811,135 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vertex Pharmaceuticals Inc |
VRTX |
EVP Chief Patient & Ex... |
2024-05-15 |
55,325 |
2024-05-15 |
7,447 |
Premium* |
|
Celladon Corp |
CLDN |
|
2022-03-11 |
16,000 |
2020-03-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
193 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2018-06-29 |
4 |
OE |
$86.52 |
$364,148 |
D/D |
4,096 |
50,758 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2019-02-04 |
4 |
OE |
$86.52 |
$364,235 |
D/D |
4,097 |
48,817 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2019-11-04 |
4 |
OE |
$86.52 |
$364,235 |
D/D |
4,097 |
37,513 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2020-02-03 |
4 |
OE |
$86.52 |
$364,239 |
D/D |
4,097 |
40,287 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2018-02-26 |
4 |
AS |
$170.00 |
$366,350 |
D/D |
(2,155) |
46,662 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2018-02-05 |
4 |
OE |
$77.31 |
$367,327 |
D/D |
4,520 |
43,683 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2018-11-02 |
4 |
AS |
$171.93 |
$372,505 |
D/D |
(2,155) |
46,662 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2018-08-02 |
4 |
AS |
$175.06 |
$380,852 |
D/D |
(2,155) |
46,662 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2019-10-25 |
4 |
OE |
$91.05 |
$392,517 |
D/D |
4,311 |
37,727 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Affairs & Pub Policy |
|
2011-02-23 |
4 |
OE |
$18.93 |
$451,064 |
D/D |
23,828 |
67,954 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
|
2014-10-28 |
4 |
OE |
$39.05 |
$468,600 |
D/D |
12,000 |
50,671 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
|
2014-11-28 |
4 |
OE |
$39.05 |
$468,600 |
D/D |
12,000 |
90,671 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
|
2015-01-09 |
4 |
OE |
$39.05 |
$468,600 |
D/D |
12,000 |
90,671 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Affairs & Pub Policy |
|
2011-03-03 |
4 |
AS |
$49.50 |
$471,785 |
D/D |
(9,531) |
40,154 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2018-01-23 |
4 |
OE |
$86.52 |
$503,892 |
D/D |
5,824 |
44,987 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
|
2015-03-18 |
4 |
OE |
$39.05 |
$508,748 |
D/D |
12,000 |
101,984 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2021-02-10 |
4 |
D |
$214.16 |
$518,481 |
D/D |
(2,421) |
68,002 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2020-08-03 |
4 |
AS |
$276.96 |
$540,137 |
D/D |
(1,941) |
35,103 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2019-11-25 |
4 |
OE |
$109.14 |
$545,700 |
D/D |
5,000 |
38,416 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2019-12-09 |
4 |
OE |
$109.14 |
$545,700 |
D/D |
5,000 |
38,416 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2020-01-08 |
4 |
OE |
$109.14 |
$545,700 |
D/D |
5,000 |
41,190 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
|
2015-03-20 |
4 |
OE |
$45.11 |
$546,649 |
D/D |
12,000 |
101,984 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Affairs & Pub Policy |
|
2012-09-14 |
4 |
AS |
$58.00 |
$552,798 |
D/D |
(9,531) |
21,108 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Affairs & Pub Policy |
|
2012-09-21 |
4 |
AS |
$59.00 |
$562,329 |
D/D |
(9,531) |
21,108 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Global Gov. Strategy |
|
2013-07-11 |
4 |
AS |
$84.00 |
$588,000 |
D/D |
(7,000) |
28,987 |
0 |
- |
|
193 Records found
|
|
Page 4 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|